Skip to main content
SpringerLink
Log in

Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo

  • Research Papers
  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Tissue inhibitors of metalloproteinases (TIMPs) are negative regulators of matrix metalloproteinases (MMPs) which degrade major components of the extracellular matrix. The aberrant expression of TIMPs is believed to represent an important modulating factor in the invasive capacity of human tumors. In the present study we analyzed the expression of TIMPs in human brain tumor tissue samples by an enzyme-linked immunosorbent assay (ELISA) and by Northern blotting analysis. Quantitation of TIMP-1 and TIMP-2 by ELISA demonstrated low levels of TIMP-1 and TIMP-2 proteins in glioblastomas, and moderate levels in anaplastic astrocytomas compared with normal brain tissues low-grade gliomas and metastatic tumors (renal and breast carcinomas and melanomas). Northern blot analysis of TIMP-1 transcripts demonstrated higher expression in meningioma, normal brain tissues and other metastatic tumors than in anaplastic astrocytoma and glioblastoma. Two distinct transcripts of 1.0 and 3.5 kb were observed for TIMP-2 mRNA in normal brain tissue and in tumor extracts. In addition, TIMP-2 mRNA expression was lower in glioblastoma and anaplastic astrocytoma than in meningioma, normal brain tissues and metastatic tumors. These findings suggest that down-regulation of both TIMP-1 and TIMP-2 contributes significantly to the invasive potential of human glioblastoma multiforme and anaplastic astrocytomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Matrisian LM, 1992, The matrix-degrading metalloproteinases. Bioessays, 14, 455–63.

    Google Scholar 

  2. Woessner JF, 1991, Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J, 5, 2145–54.

    Google Scholar 

  3. Stetler-Stevenson WG, Krutzsch HC and Liotta LA, 1989, Tissue inhibitor of metalloproteinase (TIMP-2): A new member of the metalloproteinase inhibitor family. J Biol Chem, 264, 17374–8.

    Google Scholar 

  4. Goldberg GI, Marmer BL, Grant GA, et al. 1989, Human 72-kDa type IV collagenase forms a complex with tissue inhibitor of metalloproteinase designated TIMP-2. Proc Natl Acad Sci USA, 86, 8207–11.

    Google Scholar 

  5. Goldberg GI, Strongin A, Collier IE, Genrich LT and Marmer BL, 1992, Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinase prevents dimerization, complex formation with interstitial collagenase and activation of the proenzyme with stromelysin. J Biol Chem, 267, 4583–91.

    Google Scholar 

  6. Howard EW, Bullen EC and Banda MJ, 1991, Regulation of autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinase-2. J Biol Chem, 266, 13064–9.

    Google Scholar 

  7. Circola A, Welgus HG, Pierce GF, Kramer K and Strunk RC, 1991, Differential regulation of the expression of proteinase/antiproteinases in fibroblasts. J Biol Chem, 266, 12283–8.

    Google Scholar 

  8. Nomura S, Hogan BLM, Wills AJ, Heath JK and Edwards DR, 1989, Developmental expression of tissue inhibitor of metalloproteinase (TIMP) RNA. Development, 105, 575–83.

    Google Scholar 

  9. Sato H, Kida Y, Mai M et al, 1992, Expression of genes encoding type IV collagen degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene, 7, 77–83.

    Google Scholar 

  10. Rutka JT, Myatt CA, Giblin JR, Davis RL and Rosenblum ML, 1987, Distribution of extracellular matrix proteins in primary human brain tumors: an immunohistochemical analysis. Can J Neurol Sci, 14, 25–30.

    Google Scholar 

  11. Lund-Johansen M, Rucklidge GJ, Milne G and Bjerkvig RA, 1991, Metalloproteinase capable of destroying cultured brain tissue isolated from rat glioma cells. Anticancer Res, 11, 1000–6.

    Google Scholar 

  12. Nakano A, Tani E, Miyazaki K, Furuyama J and Matsummoto T, 1993, Expression of matrilysin and stromelysin in human glioma cells. Biochem Biophys Res Commun, 192, 999–1003.

    Google Scholar 

  13. Rao JS, Steck PA, Mohanam S, et al. 1993, Elevated levels of M, 92 000 type IV collagenase in human brain tumors. Cancer Res, 53, 2208–11.

    Google Scholar 

  14. Bradford MM, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem, 72, 248–254.

    Google Scholar 

  15. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT and Liotta LA, 1990, Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem, 265, 13833–8.

    Google Scholar 

  16. Mohanam S, Sawaya R, McCutcheon I, et al. 1993, Modulation of in vitro invasion of human glioblastoma cells by urokinase type plasminogen activator receptor antibody. Cancer Res, 53, 4143–7.

    Google Scholar 

  17. Kubota S, Fridman R and Yamada Y, 1992, Transforming growth factor-β suppresses the invasiveness of human fibrosarcoma cells in vitro by increasing expression of tissue inhibitor of metalloprotease. Biochem Biophys Res Commun, 176, 129–36.

    Google Scholar 

  18. Mackay AR, Ballin M, Pelina MD, et al. 1992, Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Inv Metastasis, 12, 168–84.

    Google Scholar 

  19. Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ and Edward DR, 1993, Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncol Res, 5, 19–28.

    Google Scholar 

  20. Apodaca G, Rutka JT, Bouhana K, et al. 1990, Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res, 50, 2322–39.

    Google Scholar 

  21. Campo E, Merino MJ, Tavassoli FA, et al. 1992, Evaluation of basement membrane components and the 72-kDa type IV collagenase in serous tumors of the ovary. Am J Surg Pathol, 16, 500–7.

    Google Scholar 

  22. Monteagudo C, Merino MJ, San-Juan J, Liotta LA and Stetler-Stevenson WG, 1990, Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissues. Am J Pathol, 136, 585–92.

    Google Scholar 

  23. Stearns ME and Wanga M, 1993, Type IV collagenase (Mr 72000) expression in human prostate: benign and malignant tissue. Cancer Res, 5, 878–83.

    Google Scholar 

  24. Okada Y, Tsuchiya H, Shimizu H, et al. 1990, Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha. Biochem Biophys Res Commun, 171, 610–7.

    Google Scholar 

  25. Overall VM, Wrana JL and Sodek J, 1991, Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor β-1 in human fibroblasts. J Biol Chem, 266, 14064–71.

    Google Scholar 

  26. DeClerck YA, Yean TD, Ratzkin BJ, Lu HS and Langley KE, 1989, Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem, 264, 17445–53.

    Google Scholar 

  27. Kokha R and Ruther U, 1993, Transgenic mice with hepatic TIMP-1 alteration: a model to study the role of TIMP-1 in liver carcinogenesis. Proc AACR, 34, 121.

    Google Scholar 

  28. Fridman R, Bird RE, Hoyhtya M, et al. 1993, Expression of human recombinant 72-kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme. Biochem J, 289, 411–6.

    Google Scholar 

  29. Strongin AY, Marmer BL, Grang GA and Goldberg GI, 1993, Plasma membrane dependent activation of the 72 kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem, 268, 14033–9.

    Google Scholar 

  30. Khokha R, Zimmer MJ, Graham CH, Lala PK and Waterhouse P, 1992, Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. JNCI, 84, 1017–22.

    Google Scholar 

  31. Testa JE, 1992, Loss of the metastatic phenotype by a human epidermoid carcinoma cell line HEp-3 is accompanied by increased expression of tissue inhibitor of metalloproteinase 2. Cancer Res, 53, 5597–603.

    Google Scholar 

  32. Alvarez OA, Carmichael DF and De Clerck YA, 1990, Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinase. JNCI, 82, 589–95.

    Google Scholar 

  33. Tsuchiya Y, Sato H, Endo Y, et al. 1993, Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line KKLS in the chick embryo. Cancer Res, 53, 1397–402.

    Google Scholar 

  34. De Clerck YA, Perez N, Shimada H, et al. 1992, Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res, 52, 701–8.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX

    Sanjeeva Mohanam, Shang Wu Wang, Alan Rayford, Masaaki Yamamoto, Raymond Sawaya & Jasti S. Rao

  2. Department of Tumor Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

    Garth L. Nicolson

  3. Laboratory of Pathology, NCI, Bethesda, MD, USA

    Lance A. Liotta & William G. Stetler-Stevenson

  4. Division of Bioactive Substances, University of Tokyo, Japan

    Motowo Nakajima

Authors
  1. Sanjeeva Mohanam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shang Wu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alan Rayford
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masaaki Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Raymond Sawaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Motowo Nakajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lance A. Liotta
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Garth L. Nicolson
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. William G. Stetler-Stevenson
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jasti S. Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mohanam, S., Wu Wang, S., Rayford, A. et al. Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo . Clin Exp Metast 13, 57–62 (1995). https://doi.org/10.1007/BF00144019

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00144019

Keywords

Search

Navigation